Canton Strategic Holdings (CNTN) Profit After Tax (QoQ) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.94% |
| Dec 31, 2025 | -1,299.61% |
| Sep 30, 2025 | -13.30% |
| Jun 30, 2025 | 27.01% |
| Mar 31, 2025 | 33.47% |
| Dec 31, 2024 | -0.65% |
| Sep 30, 2024 | -63.26% |
| Jun 30, 2024 | -3.06% |
| Mar 31, 2024 | 8.80% |
| Dec 31, 2023 | -35.91% |
| Sep 30, 2023 | 22.11% |
| Jun 30, 2023 | 13.07% |
| Mar 31, 2023 | -52.19% |
| Dec 31, 2022 | 16.97% |
| Sep 30, 2022 | -29.97% |
| Jun 30, 2022 | 44.37% |
| Mar 31, 2022 | -219.95% |
| Dec 31, 2021 | 387.42% |
| Sep 30, 2021 | 45.16% |
| Jun 30, 2021 | 30.84% |